PETER P. PFREUNDSCHUH
CIK 1585839 · EVP, CFO and Treasurer · last filed 2025-09-18
PETER P. PFREUNDSCHUH is an EVP, CFO and Treasurer who has filed 35 SEC Form 4 insider transactions across 6 companies since 2013. Across all open-market trades the lifetime net is −$317.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.02M
6
35
-$317.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Y-mAbs Therapeutics, Inc. (YMAB) Delisted | CFO and Treasurer | 77,800 | $8.61 | $669.9K | $0 | 2 | 2025-01-22 |
| VYGR | Chief Financial Officer | 175,669 | $3.04 | $534.0K | -$122.9K | 6 | 2024-02-22 |
| Korro Bio, Inc. (FREQ) Delisted | Chief Financial Officer | 209 | $14.98 | $3.1K | -$27.6K | 6 | 2022-02-23 |
| URGN | Chief Financial Officer | 11,829 | $40.88 | $483.6K | -$166.7K | 11 | 2020-10-16 |
| Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | CFO | 0 | — | — | $0 | 3 | 2018-02-13 |
| IMMUNOMEDICS INC (IMMU) Delisted | Chief Financial Officer | 29,706 | — | — | $0 | 4 | 2015-08-24 |
Recent Filings
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-18 | — | Disp (D) | −77,800 | $0 | |
| 2025-01-22 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | +31,800 | $0 | EDGAR |
| 2024-07-12 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | +46,000 | $0 | EDGAR |
| 2024-02-22 | VYGR | Sell (S) | −3,764 | -$28.1K | EDGAR |
| 2024-02-21 | VYGR | Notice (144) | −3,764 | -$28.1K | EDGAR |
| 2024-02-16 | VYGR | Grant (A) | +30,000 | $0 | EDGAR |
| 2023-10-05 | VYGR | Sell (S) | −13,567 | -$94.8K | EDGAR |
| 2023-10-03 | VYGR | Notice (144) | −13,567 | -$94.8K | EDGAR |
| 2023-02-22 | VYGR | Grant (A) | +38,000 | $0 | EDGAR |
| 2022-10-04 | VYGR | Grant (A) | +125,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.